MyFinsight
Home
Blog
About
Contact
Other changes in
assets and...
-$6,091M
(-136.51%↓ Y/Y)
Proceeds from
redemptions/sales of short-term...
$4,576M
(15.70%↑ Y/Y)
Net income from
continuing operations...
$2,709M
(-8.88%↓ Y/Y)
Depreciation and
amortization
$1,613M
(-0.31%↓ Y/Y)
Share-based compensation
expense
$272M
(60.00%↑ Y/Y)
Asset write-offs and
impairments
$32M
(-90.70%↓ Y/Y)
Proceeds from
redemptions/sales of long-term...
$88M
(7.32%↑ Y/Y)
Other investing
activities, net
-$22M
(92.97%↑ Y/Y)
Net cash provided
by/(used in) operating...
$2,615M
(11.99%↑ Y/Y)
Net cash provided
by/(used in) investing...
$785M
(-76.02%↓ Y/Y)
Effect of
exchange-rate changes on cash...
$19M
(371.43%↑ Y/Y)
Canceled cashflow
$8,102M
Canceled cashflow
$3,901M
Net
increase/(decrease) in cash and cash...
$563M
(50.13%↑ Y/Y)
Canceled cashflow
$2,856M
something is missing
-$7,824M
Benefit plan
contributions in excess of...
$173M
(-24.45%↓ Y/Y)
Other adjustments,
net
$93M
(332.50%↑ Y/Y)
Deferred taxes
-$12M
(98.19%↑ Y/Y)
Purchases of short-term
investments
$2,569M
(-9.00%↓ Y/Y)
Net (purchases
of)/proceeds from...
$792M
(-79.44%↓ Y/Y)
Purchases of property,
plant and equipment
$436M
(-22.70%↓ Y/Y)
Purchases of long-term
investments
$104M
(-22.39%↓ Y/Y)
Net cash provided
by/(used in) financing...
-$2,856M
(45.36%↑ Y/Y)
Cash dividends paid
$2,445M
(0.33%↑ Y/Y)
Other financing
activities, net
-$284M
(20.22%↑ Y/Y)
Net (payments
on)/proceeds from short-term...
-$127M
(67.10%↑ Y/Y)
Back
Back
Cash Flow
Pfizer_(2021)-svg
PFIZER INC (PFE)
Pfizer_(2021)-svg
PFIZER INC (PFE)
source: myfinsight.com